» Articles » PMID: 35329886

Risk Stratification of Endoscopic Submucosal Dissection in Colon Tumors

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Mar 25
PMID 35329886
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic submucosal dissection (ESD) is a technique proven effective in the treatment of early neoplastic lesions in the gastrointestinal tract. However, in the case of colon lesions, many doubts remain. The purpose of our study is to stratify the success rates of the ESD procedure in the colon. Materials and Methods: A retrospective analysis of 601 patients who underwent ESD procedure for colorectal neoplasm from 2016 to 2019 in Center of Bowel Treatment, Brzeziny, Poland. Excluding 335 rectal neoplasms, we selected 266 patients with lesions located in the colon. Results: Lesions located in the left colon were characterized by the statistically higher en bloc resection and success rate, compared with the right colon—87.76% vs. 73.95% (p = 0.004) and 83.67% vs. 69.75% (p = 0.007), respectively. The success rate was significantly lower in lesions with submucosal cancer, compared to low- and high-grade dysplasia (p < 0.001). Polyps located in the right colon were characterized by a slightly higher complication rate compared to the left colon, without statistical significance—13.45% vs. 9.52% (p = 0.315). Conclusions: Our results show that colonic ESD has a high success rate, especially in the left colon, with a low risk of complications, slightly higher than in the right colon.

Citing Articles

Conventional versus rubber band traction-assisted endoscopic submucosal dissection for rectal neuroendocrine tumors: a single-center retrospective study (with video).

Peng J, Lin J, Fang L, Zhou J, Song Y, Yang C Surg Endosc. 2024; 38(11):6485-6492.

PMID: 39271513 PMC: 11525419. DOI: 10.1007/s00464-024-11244-5.


Endoscopic approaches to the management of dysplasia in inflammatory bowel disease: A state-of-the-art narrative review.

Singh A, Desai A, Dziegielewski C, Kochhar G Indian J Gastroenterol. 2024; 43(5):905-915.

PMID: 39060902 DOI: 10.1007/s12664-024-01621-2.


Risk Factors for Post-Endoscopic Submucosal Dissection Electrocoagulation Syndrome in Patients with Colorectal Neoplasms: A Multicenter, Large-Scale, Retrospective Cohort Study by the Honam Association for the Study of Intestinal Disease (HASID).

Song H, Kim S, Lee J, Jin B, Kim D, Kim H J Clin Med. 2024; 13(13).

PMID: 38999497 PMC: 11242390. DOI: 10.3390/jcm13133932.

References
1.
Hisabe T, Nagahama T, Hirai F, Matsui T, Iwashita A . Clinical outcomes of 200 colorectal endoscopic submucosal dissections. Dig Endosc. 2012; 24 Suppl 1:105-9. DOI: 10.1111/j.1443-1661.2012.01267.x. View

2.
Peery A, Cools K, Strassle P, McGill S, Crockett S, Barker A . Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States. Gastroenterology. 2018; 154(5):1352-1360.e3. PMC: 5880740. DOI: 10.1053/j.gastro.2018.01.003. View

3.
Fujiya M, Tanaka K, Dokoshi T, Tominaga M, Ueno N, Inaba Y . Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms: a meta-analysis of studies comparing EMR and endoscopic submucosal dissection. Gastrointest Endosc. 2015; 81(3):583-95. DOI: 10.1016/j.gie.2014.07.034. View

4.
Park J, Cheon J, Kwon J, Shin J, Jeon S, Bok H . Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer. Gastrointest Endosc. 2011; 74(6):1337-46. DOI: 10.1016/j.gie.2011.07.069. View

5.
Wang J, Zhang X, Ge J, Yang C, Liu J, Zhao S . Endoscopic submucosal dissection vs endoscopic mucosal resection for colorectal tumors: a meta-analysis. World J Gastroenterol. 2014; 20(25):8282-7. PMC: 4081704. DOI: 10.3748/wjg.v20.i25.8282. View